ON3 Vision
In a place where urban vitality and suburban flexibility meet, a new kind of community is on the rise.
With master planning underway, ON3 represents New Jersey's largest contemplated redevelopment right in the heart of the Northeast’s thriving life science corridor. Spanning the Township of Nutley and the City of Clifton, ON3 hopes to serve as a showplace for the "new urbanist" philosophy that is driving the suburban municipalities to redesign their downtowns and commercial corridors for 24/7 convenience living.
This ambitious initiative hopes to transform the former ROCHE campus into a next-generation lifestyle hub that will integrate an appropriate mix of office, R&D, residential and retail along with potential lodging and entertainment concepts. If redeveloped properly, ON3 will attract a wide array of users that will become part of the fabric of the community for the long-term. This world-class campus hopes to evolve into a place to live, work, learn or just be you without sacrificing a thing.
Redeveloping existing buildings
The redevelopment of the former ROCHE site encompasses an extensive multi-stage buildout that will likely take several years. Throughout this process, Prism Capital Partners will continue working closely with the Township of Nutley and City of Clifton to promote longevity through inclusion of an appropriate mix of uses. The first stage of creating ON3’s tremendous new work environment and life science ecosystem will focus on the 1.2 million square feet of space in the existing five buildings.
Improvements for New Medical School ON3
Improvements are underway to convert two major buildings (123 and 123A Metro Boulevard) to accommodate the needs of the new Seton Hall-Hackensack Meridian Graduate School of Medicine, the state's first private medical school in 50 years. This flagship project, slated to open in 2018, is a joint plan of Hackensack Meridian Health and Seton Hall University, which committed to leasing the two seven-story buildings, totaling 477,000 SF and 16 acres on the campus.
Interested to learn more?
Learn more about the new companies coming to ON3!
Class-A Office Space Renovations
Renovations are underway for Class-A office leasing opportunities
at 100 & 200 Metro Boulevard. A variety of industries, including bio-pharmaceutical, consumer product, entertainment and fashion businesses have expressed interest in 100 & 200 Metro Boulevard, which are now leasing a total of 500,000 SF.
Improvements are underway for 100 Metro Boulevard, a seven-story, 255,000 SF Class A office leasing opportunity. Created by The Hillier Group, the building was one of the first in New Jersey to “re-think” the workspace as an open plan to provide enhanced natural light in the interior of the space as well as increase interdepartmental communication through efficient floor plan design. A seven-story granite and glass staircase provides ease of communication from floor to floor as well as huddle areas for group meetings, fostering a collaborative work environment.
200 Metro Boulevard, the former Roche headquarters building, offers 306,000 SF of Class
A office space available for lease. Ownership is proposing to create an entirely new entrance identity for the building along with a new glass curtain wall on the eastern exposure. This new façade will provide for uninterrupted views of Manhattan to the east.
At 15 stories, this building is the tallest commercial property in Northern New Jersey (outside of the Jersey City waterfront and Newark). The building is certified LEED Gold by the U.S. Green Building Council.
Future Development
Negotiations are also underway for purpose-build facilities on the campus’ vacant land available in Clifton and Nutley. This variety of build-to-suit space hopes to bring exciting residential, retail and service opportunities, which will contribute significantly to the local economy.
1.1M SF
Future Office/R&D/Medical
635K SF
Existing R&D/Education
20 AC
Green Space
5 BUS LINE
Transit Hub
proposed
180-ROOM
Mid-rise Hotel
proposed
180K SF
Retail Amenities
proposed
1.1M SF
Residential
Multi-modal transportation
ON3 is currently being considered by NJ Transit as a Transit Oriented Development (TOD) site due to its close proximity to public transportation, and pedestrian and bicyclist oriented design. At ON3, walkability and connectivity are fundamental to creating the ultimate environment for just about anything you want to do.
Streets within the campus have been renamed to honor the site’s life science offerings and history of innovation. The former 'First Avenue' is now called Metro Boulevard and ‘Fifth Avenue’ is now Ideation Way. Various improvements to manage the efficient flow of automobiles on the campus’ roadways as well as nearby exterior streets are also under review in coordination with local and state officials.
Live
ON3 is designed to grow and evolve into a place where work and life truly come into balance.
With over 1.1M SF of residential opportunities proposed, ON3 hopes to integrate seamlessly with the surrounding towns. The campus’ proposed pedestrian-oriented retail and entertainment center runs to in-town restaurants and creates an urban destination in a suburban context. A proposed integrated hospitality and lifestyle hub hopes to offer up to 180 hotel rooms, multiple restaurants, and lifestyle and leisure amenities.
Gather
Throughout the campus, walkways and bike trails connect to surrounding parks, greenways and the local downtowns.
ON3 hopes to consist of many features unique to the site, and to the region. A wide main thoroughfare with full-growth trees, a planted median, bicycle lanes and lush roundabouts. It will also be likely to feature 20 acres of greenspace where residents can lounge, office workers can unwind—and the community can gather for events throughout the year.
Research
NJ is at the heart of the Northeast’s life science corridor, and ON3 is at the center of it all.
When it comes to life science, few states attract such innovative minds and industrious spirit as New Jersey. 60% of the US pharmaceutical industry is within the NYC Metro region, and 13 of the largest biopharmaceutical companies in the world are in New Jersey. With more than 3,100 facilities operating across all sectors, life sciences employ over 116,000 people and contribute an estimated $47.5 billion annually to the state’s economy.
